These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26134255)

  • 1. Botulinum Toxin as a Pain Killer: Players and Actions in Antinociception.
    Kim DW; Lee SK; Ahnn J
    Toxins (Basel); 2015 Jun; 7(7):2435-53. PubMed ID: 26134255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The analgesic effects of botulinum neurotoxin by modulating pain-related receptors; A literature review.
    Hosseindoost S; Askari Rad M; Inanloo SH; Rahimi M; Dehghan S; Orandi A; Dehpour AR; Majedi H
    Mol Pain; 2024; 20():17448069241275099. PubMed ID: 39093638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status and future directions of botulinum neurotoxins for targeting pain processing.
    Pellett S; Yaksh TL; Ramachandran R
    Toxins (Basel); 2015 Nov; 7(11):4519-63. PubMed ID: 26556371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum neurotoxin for pain management: insights from animal models.
    Pavone F; Luvisetto S
    Toxins (Basel); 2010 Dec; 2(12):2890-913. PubMed ID: 22069581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and molecular mechanisms involved in the analgesic effects of botulinum neurotoxin: A literature review.
    Hosseindoost S; Inanloo SH; Pestehei SK; Rahimi M; Yekta RA; Khajehnasiri A; Rad MA; Majedi H; Dehpour AR
    Drug Dev Res; 2024 Apr; 85(2):e22177. PubMed ID: 38528637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin A, brain and pain.
    Matak I; Lacković Z
    Prog Neurobiol; 2014; 119-120():39-59. PubMed ID: 24915026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of botulinum toxin in management of pain: an evidence-based review.
    Qerama E; Fuglsang-Frederiksen A; Jensen TS
    Curr Opin Anaesthesiol; 2010 Oct; 23(5):602-10. PubMed ID: 20585245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurobiological mechanisms of botulinum neurotoxin-induced analgesia for neuropathic pain.
    Bagues A; Hu J; Alshanqiti I; Chung MK
    Pharmacol Ther; 2024 Jul; 259():108668. PubMed ID: 38782121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel therapeutics based on recombinant botulinum neurotoxins to normalize the release of transmitters and pain mediators.
    Dolly JO; Wang J; Zurawski TH; Meng J
    FEBS J; 2011 Dec; 278(23):4454-66. PubMed ID: 21645262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new wrinkle on pain relief: re-engineering clostridial neurotoxins for analgesics.
    Foster KA
    Drug Discov Today; 2005 Apr; 10(8):563-9. PubMed ID: 15837599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A closer look to botulinum neurotoxin type A-induced analgesia.
    Guo BL; Zheng CX; Sui BD; Li YQ; Wang YY; Yang YL
    Toxicon; 2013 Sep; 71():134-9. PubMed ID: 23747735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanisms of action of botulinum toxins and neurotoxins].
    Poulain B; Lonchamp E; Jover E; Popoff MR; Molgó J
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S73-6. PubMed ID: 19576489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuro-exocytosis: botulinum toxins as inhibitory probes and versatile therapeutics.
    Dolly JO; Lawrence GW; Meng J; Wang J; Ovsepian SV
    Curr Opin Pharmacol; 2009 Jun; 9(3):326-35. PubMed ID: 19394272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered botulinum neurotoxins as new therapeutics.
    Masuyer G; Chaddock JA; Foster KA; Acharya KR
    Annu Rev Pharmacol Toxicol; 2014; 54():27-51. PubMed ID: 24016211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum Neurotoxins and Cancer-A Review of the Literature.
    Mittal SO; Jabbari B
    Toxins (Basel); 2020 Jan; 12(1):. PubMed ID: 31948115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical uses of botulinum neurotoxins: current indications, limitations and future developments.
    Chen S
    Toxins (Basel); 2012 Oct; 4(10):913-39. PubMed ID: 23162705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel therapeutic uses and formulations of botulinum neurotoxins: a patent review (2012 - 2014).
    Kane CD; Nuss JE; Bavari S
    Expert Opin Ther Pat; 2015 Jun; 25(6):675-90. PubMed ID: 25842964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum neurotoxins: mechanism of action.
    Tighe AP; Schiavo G
    Toxicon; 2013 Jun; 67():87-93. PubMed ID: 23201505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum Neurotoxins beyond Neurons: Interplay with Glial Cells.
    Luvisetto S
    Toxins (Basel); 2022 Oct; 14(10):. PubMed ID: 36287971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition of neurotransmitter release by tetanus and botulinum neurotoxins].
    Mochida S
    Seikagaku; 1994 Mar; 66(3):254-9. PubMed ID: 7909831
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.